Class Action

Taxotere Lawsuit

The chemotherapy drug Taxotere has been linked to permanent hair loss in breast cancer patients. Permanent hair loss, also called alopecia, is a devastating side effect that could cause a severe impairment in your quality of life.

If you took Taxotere during your cancer treatment and suffered permanent hair loss, our reputable dangerous drug lawyers may be able to file a Taxotere lawsuit to obtain compensation. We can manage every aspect of the legal process and have the resources and knowledge to investigate and build a strong case as we fight for your best interests.

You can discuss your situation in a free consultation with one of our trusted lawyers. There is no obligation to pursue a case, and if you do, there will be no fees or costs unless you receive compensation.

Fill out a Free Case Evaluation form or call The Law Offices of Peter T. Nicholl today at 410-244-7005.

Taxotere Side Effects

The U.S. Food and Drug Administration (FDA) approved Taxotere in 1996 for the treatment of breast, stomach, prostate, neck and lung cancer.

The drug is most frequently used for the treatment of advanced-stage breast cancer after other chemotherapy drugs or treatments have been unsuccessful. The American Cancer Society even includes Taxotere on its list of drugs that are most commonly used in the treatment of breast cancer.

Unfortunately, research has shown that Taxotere can cause a condition called permanent alopecia, or permanent baldness. Some patients who took Taxotere have been left with small clumps or fine wisps of hair after their hair did not come back after years of chemotherapy treatment. Many chemotherapy drugs can cause hair loss, but this side effect is usually temporary.

Taxotere Hair Loss

One of the first studies to point out the connection between Taxotere and permanent alopecia was a study done by an oncologist in 2006. The study revealed that six percent of breast cancer patients who were treated with Taxotere suffered permanent baldness.    

Other studies followed in 2010 and 2013, both noting that permanent baldness was a potential side effect of taking Taxotere for the treatment of breast cancer. The 2010 study was published in the Journal of the American Academy of Dermatology on May 14 of that year. The 2013 study was published in the Annals of Oncology. The conclusion of the study advised doctors and patients to be aware of these side effects.

FDA Updates Taxotere Labels

Despite research and reports of permanent baldness in breast cancer patients, the Taxotere label did not warn about these risks until the FDA required Sanofi-Aventis to update the label in December 2015. The new label says permanent hair loss has been observed in some cases. Prior to this update, the label said hair generally grows back after the completion of chemotherapy treatment.

The FDA's update of the Taxotere label came about five years after warnings were added to labels in Europe and three years after warnings were added to labels in Canada.

If you took Taxotere before the label was updated and you suffered permanent hair loss, you may be able to file a Taxotere lawsuit against the manufacturer for failing to give you a proper warning about the risks of this medication.  

Contact a Taxotere lawyer today to determine your legal options.

Lawsuits Over Permanent Hair Loss

Sanofi-Aventis is currently facing thousands of Taxotere lawsuits from survivors of breast cancer and their families over permanent hair loss caused by this medication.

By October 2016, so many lawsuits had been filed that the U.S. Judicial Panel on Multidistrict Litigation decided to create a multidistrict litigation (MDL) to centralize cases. The purpose of an MDL is to give the judicial system a more efficient way of dealing with these cases by allowing one judge to oversee all cases.

The Taxotere MDL is known as MDL-2740 IN RE: Taxotere (Docetaxel) Products Liability Litigation and as of December 2017, there were 3,129 cases pending out of 3,215 that had been filed. These cases are being handled in the Eastern District of Louisiana.

Allegations in Taxotere Lawsuits

These lawsuits make numerous allegations against Sanofi-Aventis about the dangers of Taxotere and how the company promoted the drug.

Some of these allegations include:

  • Selling Taxotere without disclosing all of the risks
  • Failing to provide proper warning to patients and health care professionals about the risk
  • Concealing information about Taxotere from the public
  • Creating a dangerous drug
  • Creating misleading advertising and marketing about the drug
  • Failing to determine if the drug was safe before releasing it on the market

Bellwether Trials

So far, none of the Taxotere lawsuits in the MDL have gone to trial. However, the judge in charge of the MDL has set dates for the first four bellwether trials.

Bellwether trials help both sides determine the chances of success of future cases. If the victims are successful, the defense may be more likely to settle future cases. This could lead to a quicker resolution of many of the cases in an MDL.

The dates of the first four bellwether trials are:

  • Jan. 28, 2019
  • April 8, 2019
  • July 15, 2019
  • Nov. 4, 2019

Class Action Lawsuits

Sometimes there are class action lawsuits against drug manufacturers when a lot of people have suffered similar side effects. However, there are currently no Taxotere class action lawsuits.

Three women filed a class action lawsuit in 2016. The first step in the lawsuit was asking the court to certify the victims as a class. However, the judge denied the request for class certification, which put an end to the lawsuit.

The court order denying class certification said the cases had too many differences, including:

  • Types of damages victims were seeking
  • Dosage of the drug or its generic equivalent
  • Whether a generic or the brand name drug was administered
  • The combination of chemotherapy drugs used with Taxotere or a generic equivalent
  • Number of treatment cycles

The Taxotere lawyers at our firm may be able to help you file a Taxotere lawsuit if you suffered permanent baldness after using this drug. Schedule a free legal consultation so we can review your situation and discuss all of your legal options.

We understand the devastating effect permanent baldness can have on your life. It can affect you emotionally and psychologically and you may struggle to find employment because of your condition.

Fill out a Free Case Evaluation form today.

Contact Us About Filing a Taxotere Lawsuit

The relief from breast cancer going into remission can be quickly replaced with devastation when you find out you have permanent hair loss because of the chemotherapy drugs you were taking.

This side effect is temporary with most chemotherapy drugs, but it is permanent for many people who took Taxotere. The manufacturer did not warn about the risk of permanent baldness until 2015. That means that people who took the drug before then may be able to file a Taxotere lawsuit to pursue compensation for physical, financial and emotional damages.

The defective drug attorneys at our firm have many years of experience obtaining fair compensation for victims of negligence. We have the resources and experience that will help us build a strong case.

Complete a Free Case Evaluation form or call us at 410-244-7005.

Contact our personal injury lawyers for a free consultation if you have been injured by another’s negligence. You may be entitled to compensation.



Our Offices

Local phone 410-244-7005
36 South Charles Street, Suite 1700
Baltimore, MD 21201

Local phone 757-397-6424
355 Crawford Street
Portsmouth, VA 23704